1. 798 Safety, tolerability, and immunogenicity of mRNA-4157 in combination with pembrolizumab in subjects with unresectable solid tumors (KEYNOTE-603): an update. (10th December 2020) Authors: Bauman, Julie; Burris, Howard; Clarke, Jeffrey; Patel, Manish; Cho, Daniel; Gutierrez, Martin; Julian, Ricklie; Scott, Aaron; Cohen, Pamela; Frederick, Joshua; Robert-Tissot, Celine; Zhou, Honghong; Mody, Kinjal; Keating, Karen; Meehan, Robert; Gainor, Justin Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 798 Safety, tolerability, and immunogenicity of mRNA-4157 in combination with pembrolizumab in subjects with unresectable solid tumors (KEYNOTE-603): an update. (9th November 2020) Authors: Bauman, Julie; Burris, Howard; Clarke, Jeffrey; Patel, Manish; Cho, Daniel; Gutierrez, Martin; Julian, Ricklie; Scott, Aaron; Cohen, Pamela; Frederick, Joshua; Robert-Tissot, Celine; Zhou, Honghong; Mody, Kinjal; Keating, Karen; Meehan, Robert; Gainor, Justin Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A846 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗